FCM
Farallon Capital Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.7K | Hold |
16,000
| – | – | ﹤0.01% | 127 |
|
|
2025
Q1 | $131K | Hold |
16,000
| – | – | ﹤0.01% | 125 |
|
|
2024
Q4 | $151K | Hold |
16,000
| – | – | ﹤0.01% | 128 |
|
|
2024
Q3 | $171K | Hold |
16,000
| – | – | ﹤0.01% | 140 |
|
|
2024
Q2 | $159K | Hold |
16,000
| – | – | ﹤0.01% | 141 |
|
|
2024
Q1 | $188K | Hold |
16,000
| – | – | ﹤0.01% | 145 |
|
|
2023
Q4 | $227K | Hold |
16,000
| – | – | ﹤0.01% | 120 |
|
|
2023
Q3 | $195K | Buy |
+16,000
| New | +$195K | ﹤0.01% | 129 |
|
|
2021
Q2 | – | Sell |
-100,000
| Closed | -$988K | – | 304 |
|
|
2021
Q1 | $988K | Sell |
100,000
-1,150,000
| -92% | -$11.4M | ﹤0.01% | 226 |
|
|
2020
Q4 | $28.9M | Buy |
+1,250,000
| New | +$28.9M | 0.17% | 81 |
|
|
2018
Q3 | – | Sell |
-3,655,000
| Closed | -$57.1M | – | 104 |
|
|
2018
Q2 | $57.1M | Buy |
3,655,000
+174,000
| +5% | +$2.72M | 0.35% | 46 |
|
|
2018
Q1 | $52.4M | Buy |
3,481,000
+700,000
| +25% | +$10.5M | 0.36% | 46 |
|
|
2017
Q4 | $40M | Sell |
2,781,000
-2,300,055
| -45% | -$33.1M | 0.33% | 43 |
|
|
2017
Q3 | $76.6M | Buy |
5,081,055
+2,081,055
| +69% | +$31.4M | 0.68% | 36 |
|
|
2017
Q2 | $30.2M | Buy |
+3,000,000
| New | +$30.2M | 0.31% | 47 |
|